Doctor Ewa Kwiecien
John Paul II Hospital, Krakow (Poland)
Evolution of left ventricular function after Wharton's jelly mesenchymal stem cells transcoronary administration: 5-year follow up in a pilot cohort of CIRCULATE-AMI Randomized Trial
Event: ESC Congress 2020
Topic: Treatment
Session: Acute Coronary Syndromes ePosters
Insights into left ventricular remodelling and clinical outcomes after Wharton's jelly multipotent stem cells transcoronary administration in a pilot cohort of CIRCULATE-AMI Trial (NCT03404063)
Event: ESC Congress 2019
Topic: Revascularisation
Session: Acute coronary syndrome treatment
Myocardial regeneration strategy using wharton's jelly multipotent stem cells as an 'unlimited' therapeutic agent: 3-year outcomes in a pilot cohort of circulate-acute myocardial infarction trial.
Event: ESC Congress 2018
Topic: Treatment, Other
Session: Pharmacologic treatment of acute coronary syndromes
ESC 365 is supported by
